Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- US Drug Industry Wary of Efforts to Weaken Patents
- AN INTERNATIONAL EFFORT to make pharmaceuticals more widely available in developing countries is raising concern in the US drug industry that protection for its valuable patents could be in jeopardy. The World Health Organization WHO WHO is co AN INTERNATIONAL EFFORT to make...
- Research articles 1998-05-18
- US Drug Industry Wary of Efforts to Weaken Patents.(US drug industry worried its patents could be put in jeopardy by global effort to make pharmaceuticals more widely available in developing countries)
- AN INTERNATIONAL EFFORT to make pharmaceuticals more widely available in developing countries is raising concern in the US drug industry that protection for its valuable patents could be in jeopardy. The World Health Organization WHO WHO is co AN INTERNATIONAL EFFORT to make...
- Research articles 1998-05-18
- Administration proposes pro-generics rule changes.(White House proposes to block brand-name drug companies from filing multiple patent-protection lawsuits)
- THE WHITE HOUSE proposed new regulations last week that would make it easier for generic drugs to reach the market by blocking brand-name pharmaceutical companies from filing multiple patent-protection lawsuits. "I'm taking action to clo THE WHITE HOUSE...
- Research articles 2002-10-28
Additional Resources
- Celebrities, Pharmaceutical Researchers Join Hands For Day On The Hill Educating Congressional Leaders On Proposed Changes To Patent Law That Would Hurt American Patients Waiting For New Cures
- Tuesday on Capitol Hill, celebrities joined hands with pharmaceutical company researchers to let Congressional leaders know that pending legislation would erode current patent protection laws, resulting in the serious undermining of new drug discovery and research for diseases like Alzheimer's and cancer. Patent laws encourage innovation and new drug...
- Research articles 1970-01-01
- The Bad News Behind J&J's Good Q3 Earnings and Why Pfizer is Kicking Itself as a Result
- Johnson & Johnson announced its third quarter earnings and reported good news: Sales were up year on year 6.4 percent to $15.9 billion. That topline number illustrates two things: how bad news can be concealed inside a diversified pharma play; and how dumb Pfizer was to sell J&J its consumer...
- Blog posts 2008-10-14
- Ecopia Obtains Patent Protection on ECO-4601 from the USPTO
- MONTREAL -- Ecopia BioSciences Inc. (TSX:EIA) is pleased to announce it has received a Notice of Allowance from the United States Patent and Trade-mark Office ("USPTO") for a patent application directed to ECO-4601, the Company's lead anticancer compound that is in preparation for its Phase I clinical trials. The allowed...
- Research articles 2005-12-07
- Titan Pharmaceutical: More Likely Buyout Target as Patent Protection Is Approved
- VFC submits: Titan Pharmaceuticals (TTNP.PK) announced on Monday that the company had received confirmation from the United States Patent and Trademark Office [USPTO] that a Notice of Allowance had been issued for Probuphine for the treatment of Opiate addiction. This news has been long awaited and heavily anticipated by...
- External links 2009-12-02
- Ireland's Elan hires Citi to weigh sale of company
- By Ben Hirschler and Andras Gergely LONDON/DUBLIN (Reuters) - Elan Corp Plc (ELN.I) has hired Citigroup to conduct a strategic review that could lead to a sale or merger of the company, Ireland's top drugmaker said on Tuesday, sending its shares sharply higher. The move follows criticism from some major...
- News items 2009-08-07
- Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration
- A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...
- Blog posts 2008-12-31
- Microsoft's Patent Dust-Ups
- Posted by: Aaron Ricadela on August 19 For the past half dozen years, Microsoft has been busily getting its patent house in order. In a bid to protect itself against lawsuits alleging that it has infringed on other companies' patents, Microsoft has issued more patents on its inventions and carefully...
- News items 2009-08-19
- Pozen Receives New Patent For Mt 100
- Pozen Inc.,(Nasdaq: POZN), Chapel Hill, a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, has received patent number 6,479,551 from the United States Patent and Trademark Office. This new patent provides expanded protection for MT 100 through claims relating to additional pharmaceutical compositions...
- Research articles 2003-01-01
- Abbott Laboratories Q2 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Our first question today is from Mike Weinstein. And please state your company name. Mike Weinstein - J.P. Morgan Thank you. It's J.P. Morgan. Excuse me, a couple questions if we could start-off. There was during this quarter, there was that Barron's article and there...
- Earnings calls 2007-07-18
- ASCEND Therapeutics files patent applications for drug planned to treat benign breast disease.
- ASCEND Therapeutics (Herndon, VA) announced that it has filed a patent application for both the pharmaceutical composition of TamoGel (4-hydroxytamoxifen gel) and the gel's use for the treatment of benign breast disease. The patents provide protection for ASCEND's transdermal approach to the treatment...
- Research articles 2004-08-01
- Darden Prof: Tap Outside Resources to Rev Your Innovation Engine
- Professor Michael Lenox is the executive director of the Batten Institute for Entrepreneurship and Innovation at the University of Virginia's Darden School of Business. Professor Lenox concentrates on two main areas: technology strategy and the interface of business strategy and public policy. In today's Q&A, we'll...
- Blog posts 2009-07-15
- J&J to Slash 7,000 to 8,000 Jobs
- NEW YORK (Reuters) - Johnson & Johnson said on Tuesday it plans to cut 6 percent to 7 percent of its workforce in a battle to prop up profits in the face of generic competition to its prescription drugs. The company said the cuts will affect 7,000 to 8,000 jobs,...
- News items 2009-11-03
- Higher Yield, Safe Returns: Best Investment Bets
- Money-market funds are now paying next to nothing. Boost your returns by moving some cash into higher-yielding but still relatively safe dividend stocks or bond funds. Here are five stocks and five funds that we like. ...
- Articles 2009-08-13
- Microsoft Down but Not Out in Texas
- Posted by: Aaron Ricadela on August 19 For the past half dozen years, Microsoft has been busily getting its patent house in order. In a bid to protect itself against lawsuits alleging that it has infringed on other companies' patents, Microsoft has issued more patents on its inventions and carefully...
- News items 2009-08-21
- << Previous
- page 1 of 1
- Next >>
